Novartis AG (NVS) Social Stream



Novartis AG (NVS): $84.17

-1.11 (-1.30%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Novartis Ag (NVS) Price Targets From Analysts

Use the tables below to see what analysts covering Novartis Ag think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-27 7 $108 $100 $104.333 $87.96 18.61%
2022-01-17 8 $105 $100 $102.666 $87.96 16.72%
2022-03-08 6 $105 $100 $103 $87.96 17.1%

The Trend in the Analyst Price Target


NVS's average price target has moved down $2.07 over the prior 18 months.

Over the past 132 days, NVS's average upside potential has been 22.5%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-07 8 105 100 102.666 80.68 27.25%
2022-01-03 8 105 100 102.666 87.87 16.84%
2022-02-07 8 105 100 103.000 87.21 18.11%
2022-03-08 8 105 100 103.000 80.11 28.57%
2022-03-08 6 105 100 103.000 80.11 28.57%

NVS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.33 3 0 2 1 1 6

The Trend in the Broker Recommendations


Over the past 151 days, NVS's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Novartis Ag's variance in analysts' estimates is lower than 61.32% of them.
  • To contextualize these metrics, consider that out of stocks in the mega market cap category, Novartis Ag's number of analysts covering the stock is greater than 20.66% of them.
  • NVS has a higher upside potential (average analyst target price relative to current price) than 42.27% of Pharmaceutical Products stocks.
  • In terms of how Novartis Ag fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 430.7% of that group.

Stocks similar to Novartis Ag in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NVO, MRK, and LLY.

Is NVS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6994 seconds.